Author

Kishma Vinod

Observed name: Vinod K

Institution: Bharat Serums and Vaccines (India)

Observed institutions: KLE Technological University, KLE Academy of Higher Education and Research, Bharat Serums and Vaccines (India)

ORCID: 0009-0008-2385-905X

Observed ORCID: 0009-0008-2385-905X

OpenAlex ID: A5103031008

Post-marketing safety evaluation of recombinant anti-rho (D) immunoglobulin for the prevention of maternal rh-isoimmunization: A prospective, multi-centre, phase IV study

2023 · Pratik Shah, Sweety Saigal, et al. · Indian Journal of Obstetrics and Gynecology Research · 2

A Phase 3 Noninferiority Study Comparing the Efficacy, Immunogenicity, and Safety of Foligraf®: A Biosimilar Recombinant Human Follicle-stimulating Hormone and Gonal-f® (Prefilled Pen) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology

2025 · Pratik Shah, Vidya Bhat, et al. · International Journal of Infertility & Fetal Medicine · 1

Development of Hospital Formulary for an Emergency Drug List in Tertiary Care Teaching Hospital

2024 · Jayasheela S Hiremath, Agadi Hiremath Viswanatha Swamy, et al. · International Journal of Pharmaceutical Sciences and Nanotechnology

Works count: 3

Citation count: 3

H-index: 1

I10-index: